New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...
Researchers in Denmark conducted a prospective single-centre study including 160 patients with newly diagnosed high-risk prostate cancer between 2021 and 2024. All the participants first underwent an ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Prostate-specific membrane antigen (PSMA)-PET is already a standard imaging tool in prostate cancer treatment. Now, a phase 3 clinical trial suggests the imaging modality may also help determine which ...
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph's Health Care London (Lawson), and University Health Network (UHN) has ...
A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be ...
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results